Article Text

PDF
Reference level of serum urate for clinically evident incident gout
  1. Xiao Chen1,2,
  2. Xiaoqiang Ding1
  1. 1Department of Nephrology, Zhongshan Hospital Fudan University, Shanghai Medical Center of Kidney Disease, Shanghai, China
  2. 2Department of Radiology, the Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
  1. Correspondence to Dr Xiao Chen, Department of Nephrology, Zhongshan Hospital Fudan University, Shanghai Medical Center of Kidney Disease, Shanghai 200032; Department of Radiology the Affiliated Hospital of Nanjing University of Chinese Medicine Nanjing 210029, China; chxwin{at}163.com

Statistics from Altmetric.com

I read the interesting study entitled ‘Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis’ conducted by Dalbeth and colleagues.1 Their study showed the cumulative incidence of gout was increased with the serum urate levels and the cumulative years. The reference level of serum urate below which the risk of damage is low has not been completely clarified. The benchmark dose (BMD) method, first described by Crump in 1984,2 has been widely used in the field …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles